Amgen

Xaluritamig

Biodrugs/ Drugs
Cancer
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer
1Phase I in Spain